| Product Code: ETC8049729 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Lithuania saw a shift in its pyruvate kinase import landscape with a notable decrease in market concentration, moving from high concentration in 2023 to low concentration. The top exporting countries to Lithuania were the USA, Denmark, Netherlands, Poland, and Germany. Despite the challenging CAGR of -19.41% from 2020 to 2024, there was a slight improvement in the growth rate in 2024, with a decline of -18.79% compared to the previous year. This changing dynamic suggests a diversification of import sources and potential opportunities for market development in the pyruvate kinase sector in Lithuania.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Lithuania Pyruvate Kinase Market Overview |
3.1 Lithuania Country Macro Economic Indicators |
3.2 Lithuania Pyruvate Kinase Market Revenues & Volume, 2021 & 2031F |
3.3 Lithuania Pyruvate Kinase Market - Industry Life Cycle |
3.4 Lithuania Pyruvate Kinase Market - Porter's Five Forces |
3.5 Lithuania Pyruvate Kinase Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
4 Lithuania Pyruvate Kinase Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of pyruvate kinase deficiency in Lithuania |
4.2.2 Growing awareness about the importance of early diagnosis and treatment of pyruvate kinase disorders |
4.2.3 Technological advancements in diagnostics and treatment options for pyruvate kinase deficiency |
4.3 Market Restraints |
4.3.1 High cost associated with pyruvate kinase deficiency diagnosis and treatment |
4.3.2 Limited reimbursement policies for pyruvate kinase therapies in Lithuania |
5 Lithuania Pyruvate Kinase Market Trends |
6 Lithuania Pyruvate Kinase Market, By Types |
6.1 Lithuania Pyruvate Kinase Market, By Drugs |
6.1.1 Overview and Analysis |
6.1.2 Lithuania Pyruvate Kinase Market Revenues & Volume, By Drugs, 2021- 2031F |
6.1.3 Lithuania Pyruvate Kinase Market Revenues & Volume, By Pyrukynd (Mitapivat), 2021- 2031F |
6.1.4 Lithuania Pyruvate Kinase Market Revenues & Volume, By RPL301, 2021- 2031F |
7 Lithuania Pyruvate Kinase Market Import-Export Trade Statistics |
7.1 Lithuania Pyruvate Kinase Market Export to Major Countries |
7.2 Lithuania Pyruvate Kinase Market Imports from Major Countries |
8 Lithuania Pyruvate Kinase Market Key Performance Indicators |
8.1 Number of healthcare providers offering pyruvate kinase deficiency screening services |
8.2 Adoption rate of advanced diagnostic technologies for pyruvate kinase disorders in healthcare facilities |
8.3 Patient adherence to pyruvate kinase deficiency treatment regimens |
8.4 Number of research studies or clinical trials focused on pyruvate kinase deficiency in Lithuania |
9 Lithuania Pyruvate Kinase Market - Opportunity Assessment |
9.1 Lithuania Pyruvate Kinase Market Opportunity Assessment, By Drugs, 2021 & 2031F |
10 Lithuania Pyruvate Kinase Market - Competitive Landscape |
10.1 Lithuania Pyruvate Kinase Market Revenue Share, By Companies, 2024 |
10.2 Lithuania Pyruvate Kinase Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |